Articles tagged "Post-operative complications"

2022 American Transplant Congress
The Enhanced Recovery After Surgery (ERAS) Program for Donor Hepatectomy; Useful Method for Donor Safety? Or Unnecessary Hindrance?
H. Choi¹, G. Na², H. Park¹, Y. Woo¹, Y. Choi¹, S. Park¹, Y. You¹
¹Seoul St. Mary's hospital, The Catholic University of Korea, Seoul, Korea, Republic of, ²Bucheon St. Mary's hospital, The Catholic University of Korea, Bucheon, Korea, Republic of
*Purpose: Enhanced recovery after surgery (ERAS) programs have been reported to reduce the rate of postoperative complications and shorten hospital stays in liver surgery. However,…
2022 American Transplant Congress
Risk Factors Associated with Medium-Term Allograft and Recipient Survival: Learned from 1,587 Adults with Single Kidney Transplantation
S. Chang¹, B. Liu¹, D. Du¹, N. Gong², L. Zhu¹, G. Chen¹, W. Zhang¹, Z. Chen²
¹Institute of Organ Transplantation,Tongji Hospital,Tongji Medical College,HUST, Wuhan, China, ²Huazhong University of Science and Technology, Wuhan, China
*Purpose: Retrospectively investigated the reason for graft failure during the perioperative period and discussed whether DGF and the high SCr level in a short time…
2022 American Transplant Congress
Liver Transplantation for Primary Sclerosing Cholangitis (psc): Experience from the Last Three Decades
J. Zhu¹, D. Lim¹, L. James¹, E. Yoshida², K. Peltekian¹
¹Medicine, Dalhousie University, Halifax, NS, Canada, ²Medicine, University of British Columbia, Vancouver, BC, Canada
*Purpose: In liver transplantation (LT) for PSC, pre-transplant colectomy may lower the risk of PSC recurrence (rPSC), and well-controlled or lack of IBD may protect…
2022 American Transplant Congress
Poor Tolerability of CFTR Modulator Therapy in Lung Transplant Recipients
C. Doligalski, C. McKinzie, A. Yang, R. Coakley
UNC Health, Chapel Hill, NC
*Purpose: Elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) is a highly effective therapy for cystic fibrosis (CF) with potential benefits in lung transplant recipients (LTRs) for extrapulmonary CF manifestations, however…
2022 American Transplant Congress
Textbook Outcome in Lung Transplantation: Planned VA ECMO versus Off-Pump
S. E. Halpern¹, M. C. Wright², G. Madsen², B. Chow², J. C. Haney³, J. A. Klapper³, B. A. Bottiger², M. G. Hartwig³
¹Duke University School of Medicine, Durham, NC, ²Anesthesiology, Duke University Medical Center, Durham, NC, ³Surgery, Duke University Medical Center, Durham, NC
*Purpose: Planned venoarterial extracorporeal membrane oxygenation (VA ECMO) is increasingly used during bilateral orthotopic lung transplantation (BOLT) and may be superior to off-pump (OP) support…
2022 American Transplant Congress
Unique Treatment of Duodenal Perforation in Middle Aged Female Patient with Liver Transplant
H. Elshebiny¹, J. Syed-Mohammed²
¹Wayne State University School of Medicine, Detroit, MI, ²Henry Ford Health System, Detroit, MI
*Purpose: We describe a unique method of treatment of duodenal perforation due to biliary stent using an over the scope clip-OTSC.*Methods: A 68 year old…
2022 American Transplant Congress
Application of Metagenomicnext-Generation Sequencing in the Diagnosis and Treatment of Recurrent Urinary Tract Infections in Kidney Transplant Recipients
W. Duan, X. Tian, X. Wu, G. Cao, T. Yan
Henan Province People's Hospital, Zhengzhou, Henan Province, China
*Purpose: Rapid and accurate pathogen diagnosis is the key to the treatment of recurrent urinary tract infections (RUTI) after kidney transplant. Metagenomic next-generation sequencing (mNGS)…
2022 American Transplant Congress
Outcomes in Lung Transplant Recipients Switched from Tacrolimus to Cyclosporine Due to Hyperammonemia Early Post-Transplantation
S. Goyal, J. Lyons, P. Stracener, B. Bemiss
Loyola University Medical Center, Chicago, IL
*Purpose: Assess the impact of switching from tacrolimus to cyclosporine due to hyperammonemia on outcomes at 1-year post-lung transplant.*Methods: A retrospective review of lung transplant…
2022 American Transplant Congress
Risk Factors for Early Post Transplant Cardiac Dysfunction After Liver Transplantation
V. Subramanian¹, K. Bowers², H. Kalagotla², J. Buggs¹, N. Kemmer¹, K. Dhanireddy¹
¹Transplant Institute, Tampa General Hospital, Tampa, FL, ²University of South Florida, Tampa, FL
*Purpose: Cardiovascular complications after liver transplantation (LTx) are a leading cause of morbidity and mortality. The goal of this study was to evaluate risk factors…
2022 American Transplant Congress
Neighborhood Spatial Accessibility is Not Associated with Days Alive and Out of the Hospital After Kidney Transplant
J. Gunasti
Emory University, Atlanta, GA
*Purpose: Transportation-related barriers to care or to health-promoting resources are often referenced as challenges during the kidney transplant process. However, little is known about the…